Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1960 Dec;39(12):1942–1952. doi: 10.1172/JCI104219

ENZYMES AND BLOOD CLOTTING. I. TRYPSIN AS AN ACCESSORY FACTOR *

John H Ferguson 1, Ella Gray Wilson 1, Sotirios G Iatridis 1,†, Herman A Rierson 1, Betty R Johnston 1
PMCID: PMC441920  PMID: 13698885

Full text

PDF
1942

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARENDS T., FERGUSON J. H., LEWIS J. H. Hemorrhagic disease with circulating inhibitors of blood clotting: anti-AHF and anti-PTC in eight cases. Blood. 1956 Sep;11(9):846–855. [PubMed] [Google Scholar]
  2. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  3. Dale H. H., Walpole G. S. Some Experiments on Factors Concerned in the Formation of Thrombin. Biochem J. 1916 Oct;10(3):331–362. doi: 10.1042/bj0100331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FERGUSON J. H., FRESH J. W., LEWIS J. H., ZUCKER M. B. Primary hemorrhagic diseases. J Lab Clin Med. 1957 Feb;49(2):211–232. [PubMed] [Google Scholar]
  5. FERGUSON J. H., JOHNSTON C. L., Jr, HOWELL D. A. A circulation inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism. Blood. 1958 Apr;13(4):382–397. [PubMed] [Google Scholar]
  6. Ferguson J. H. A NEW BLOOD-CLOTTING THEORY. Science. 1943 Apr 9;97(2519):319–322. doi: 10.1126/science.97.2519.319. [DOI] [PubMed] [Google Scholar]
  7. HOUGIE C. Studies on the fate of coagulation factors during the clotting of normal and pathological blood. Thromb Diath Haemorrh. 1959 Sep 1;3:578–587. [PubMed] [Google Scholar]
  8. JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A., BLACK W. L. The fate of factor VII and Stuart factor during the clotting of normal blood. Thromb Diath Haemorrh. 1959 Jun 15;3:367–374. [PubMed] [Google Scholar]
  9. JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A., PAYNE R. B. Isolation of coagulation factors by continuous flow electrophoresis. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:747–750. doi: 10.3181/00379727-101-25082. [DOI] [PubMed] [Google Scholar]
  10. JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc Soc Exp Biol Med. 1958 Oct;99(1):197–201. doi: 10.3181/00379727-99-24294. [DOI] [PubMed] [Google Scholar]
  11. LANGDELL R. D., WAGNER R. H., BRINKHOUS K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med. 1953 Apr;41(4):637–647. [PubMed] [Google Scholar]
  12. LEWIS J. H., FERGUSON J. H. Partial purification of human prothrombin and proconvertin: their characteristics and interaction. J Clin Invest. 1953 Oct;32(10):915–921. doi: 10.1172/JCI102816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lewis J. H., Ferguson J. H. THROMBIN FORMATION. I. THE ROLE OF CALCIUM, SERUM AC-GLOBULIN AND TISSUE THROMBOPLASTIN. J Clin Invest. 1948 Nov;27(6):778–784. doi: 10.1172/JCI102028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. OWREN P. A. Prothrombin and accessory factors; clinical significance. Am J Med. 1953 Feb;14(2):201–215. doi: 10.1016/0002-9343(53)90019-9. [DOI] [PubMed] [Google Scholar]
  15. SEEGERS W. H., McCLAUGHRY R. I., FAHEY J. L. Some properties of purified prothrombin and its activation with sodium citrate. Blood. 1950 May;5(5):421–433. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES